Details for Patent: 9,000,021
✉ Email this page to a colleague
Which drugs does patent 9,000,021 protect, and when does it expire?
Patent 9,000,021 protects BENDEKA and is included in one NDA.
This patent has fifty patent family members in sixteen countries.
Summary for Patent: 9,000,021
Title: | Method of treating bendamustine-responsive conditions in patients requiring reduced volumes for administration |
Abstract: | Methods of treating bendamustine responsive conditions in patients having fluid and/or sodium intake restrictions are disclosed. The methods include identifying patients having such restrictions and in need of bendamustine, and then administering thereto a bendamustine-containing composition in a volume of about 120 ml or less intravenously over a period of about 15 minutes or less. The smaller volumes and reduced sodium load as compared to currently known methods of treatment minimize cardiac and/or renal stress in patients having diseases such as congestive heart failure or renal disease. |
Inventor(s): | Sundaram; Srikanth (Somerset, NJ), Tarriff; Scott L. (Mahwah, NJ) |
Assignee: | Eagle Pharmaceuticals, Inc. (Woodcliff Lake, NJ) |
Application Number: | 13/838,267 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,000,021 |
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; |
Drugs Protected by US Patent 9,000,021
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eagle Pharms | BENDEKA | bendamustine hydrochloride | SOLUTION;IV (INFUSION) | 208194-001 | Dec 7, 2015 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | FOR USE IN THE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND/OR NON-HODGKINS LYMPHOMA | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,000,021
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Canada | 2867295 | ⤷ Try a Trial | |||
Canada | 2867343 | ⤷ Try a Trial | |||
China | 104271135 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |